openPR Logo
Press release

Cancer Biomarkers Market is expected to reach US$ 31,206.00 Mn by 2027 With Bio-Rad Laboratories, Inc., Thermo Fisher Scientific, Inc., F. Hoffmann-La Roche Ltd., QIAGEN N.V., Illumina, Inc., Myriad Genetics, Inc., Hologic Inc., Quest Diagnostics Incorpor

05-04-2021 05:06 PM CET | Health & Medicine

Press release from: The Insight Partners

/ PR Agency: The Insight Partners
Cancer Biomarkers Market

Cancer Biomarkers Market

According to The Insight Partners market research titled ‘Cancer Biomarkers to 2027 – Global Analysis and Forecasts by Biomarker Type, Profiling Technology, Cancer Type, and Application.’ The global cancer biomarkers market is anticipated to reach US$ 31,206.00 Mn in 2027 from US$ 12,175.69 Mn in 2018. The market is anticipated to grow with a CAGR of 11.1% from 2019-2027. The report provides the trends prevailing in the global cancer biomarkers market and the factors driving the market along with those that act as hindrances.

For sample report click:  https://www.theinsightpartners.com/sample/TIPBT00002663/?openpr-10225

The global cancer biomarkers market, based on the biomarker type, is segmented into genetic biomarkers, protein biomarkers, and others. In 2018, the protein biomarkers segment held the largest market share of the cancer biomarkers market. This segment is also projected to dominate the market in 2027 due to the remarkable potential of protein biomarkers in cancer diagnostics, detection, and clinical & therapeutic applications and lower price of protein biomarker tests as compared to genetic biomarker tests.

The market for cancer biomarkers is expected to grow, owing to factors such as the growing cancer prevalence across the globe, new product launches & FDA approvals, and technological advancements. Moreover, emerging markets in developing countries are likely to have a positive impact on the growth of the market in the coming years.

The leading companies operating in the cancer biomarkers market include Bio-Rad Laboratories, Inc., Thermo Fisher Scientific, Inc., F. Hoffmann-La Roche Ltd., QIAGEN N.V., Illumina, Inc., Myriad Genetics, Inc., Hologic Inc., Quest Diagnostics Incorporated, bioMérieux S.A., and Creative Diagnostics among others. The market has observed various organic as well as inorganic developments during recent years in the cancer biomarkers market. For instance, in May 2019, Roche launched the VENTANA ROS1 (SP384) Rabbit Monoclonal Primary Antibody, an in vitro diagnostic ROS1 immunohistochemistry (IHC) assay. The launch has enabled the company to offer better innovative products in the market.

The report segments the Global Cancer Biomarkers Market as follows:

Global Cancer Biomarkers Market – By Biomarker Type

Genetic Biomarkers
Protein Biomarkers
Other Cancer Biomarkers Diagnostics

Global Cancer Biomarkers Market – By Profiling Technology

Omics Technologies
Imaging Technologies
Computed Tomography (CT)
Positron Emission Tomography (PET)
Magnetic Resonance Imaging (MRI)
Ultrasound
Immunoassays
Cytogenetics
Bioinformatics Antibodies

Global Cancer Biomarkers Market – By Cancer Type

Breast Cancer
Lung Cancer
Prostate Cancer
Leukemia
Bladder Cancer
Other Cancer Types

Global Cancer Biomarkers Market – By Application

Diagnostics
Research and Development
Prognostics
Other Applications

Global Cancer biomarkers market – By Geography

North America
US
Canada
Mexico
Europe
France
Germany
U.K
Spain
Italy
Asia Pacific (APAC)
China
India
Japan
Australia
South Korea
Middle East & Africa (MEA)
Saudi Arabia
U.A.E
South Africa
South & Central America (SCAM)
Brazil
Argentina
Contact Us

Interested in purchasing this Report?  Click here @ https://www.theinsightpartners.com/buy/TIPBT00002663/?openpr-10225

Contact Us:
The Insight Partners,
Phone: +1-646-491-9876
Email: sales@theinsightpartners.com

About Us:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are committed to provide highest quality research and consulting services to our customers. We help our clients understand the key market trends, identify opportunities, and make informed decisions with our market research offerings at an affordable cost.
We understand syndicated reports may not meet precise research requirements of all our clients. We offer our clients multiple ways to customize research as per their specific needs and budget

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Cancer Biomarkers Market is expected to reach US$ 31,206.00 Mn by 2027 With Bio-Rad Laboratories, Inc., Thermo Fisher Scientific, Inc., F. Hoffmann-La Roche Ltd., QIAGEN N.V., Illumina, Inc., Myriad Genetics, Inc., Hologic Inc., Quest Diagnostics Incorpor here

News-ID: 2279758 • Views: 176

More Releases from The Insight Partners

Weather Monitoring System Market with COVID-19 Impact Analysis, Top Companies Ba …
Global Weather Monitoring System Market is expected to grow at a higher rate during the forecast period 2021-2027.The report includes the latest coverage of the impact of COVID-19 on the Weather Monitoring System Market. Weather monitoring system allows users to access weather data in real time from various locations within the mobile network's coverage area. These solutions collect weather data such as temperature, humidity, wind speed and direction, rain fall,
Bioreactors Market is expected to reach US$ 5,169.01 Mn by 2027 With Thermo Fish …
According to The Insight Partners market research study on "Bioreactors Market to 2027 – Global Analysis and Forecasts by Cell, Molecule, Technology, and End User". The global bioreactors market is expected to reach US$ 5,169.01 Mn by 2027 from US$ 2,958.50 Mn in 2019. The market is estimated to grow at a CAGR of 7.3% from 2020 to 2027. The report provides trends prevailing in the global bioreactors market and
Genome Editing Market is estimated to reach US$ 10,691.0 Mn by 2025 With Transpo …
According to The Insight Partners market research study titled ‘Genome Editing Market to 2025 - Global Analysis and Forecasts by Technology, Application and End User, the global genome editing market was valued at US$ 3,210.1 Mn in 2017 and is estimated to reach US$ 10,691.0 Mn by 2025. The report highlights the trends prevalent in the global genome editing market and the factors driving the market along with the restraints
Corrugated Packaging Software Industry 2021 Market Demand, Size, Growth, Trends, …
The growth in the adoption of corrugated boxes by e-commerce vendors is driving the growth of the corrugated packaging software market. However, the high initial cost may restrain the growth of the corrugated packaging software market. Furthermore, owing to the growing variety of goods bought online, the need for corrugated boxes are rising continuously, which is anticipated to witness massive demand during the forecast period. Get Sample PDF Brochure at –

All 5 Releases


More Releases for Cancer

Cancer Therapeutics Market New Business Opportunities to Hit $180.19 billion by …
Surge in geriatric population and rise in the number of collaborations & partnerships to facilitate drug development are the key drivers of the global cancer therapeutics market. In addition, heavy inflow of investment in R&D activities has enhanced the development of cancer therapeutics. Furthermore, favorable government regulations for cancer therapeutics and surge in cancer prevalence boost the market. The high demand for personalized medicine along with high potential of emerging
Primary Prevention of Cancer
Primary prevention of cancer aims to prevent the disease before it ever occurs. More than 4 in 10 cancers as well as cancer deaths are linked to modifiable risk factors that can be altered as part of primary cancer prevention. The modifiable risk factors for primary prevention include: 1. Cigarette smoking: Smoking causes almost all cases of lung cancer and accounts for 30% of all cancer deaths. Prevention strategy for this risk
Cancer Vaccines Market
Manufacturers in the cancer vaccines market are focusing on developing new vaccines in order to treat various cancers. Through this, they are expected to gain a competitive edge in the market and increase their market share. For instance, Gilead Science Inc., in 2017, acquired Kite Pharma Inc., which is involved in development of different type of immunotherapy and vaccines. Also, Treos Bio, in 2017, collaborated with Pharmaceutical Product Development, LLC
Cancer Diagnostics Global Market: By Application - Breast Cancer, Lung Cancer, C …
Researchmoz added Most up-to-date research on "Cancer Diagnostics Global Market: By Application - Breast Cancer, Lung Cancer, Colorectal Cancer, Melanoma & Other Cancers" to its huge collection of research reports. This report studies Cancer Diagnostics in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022. This report focuses on top
Global Cancer Vaccines Market 2016: Liver cancer, Cervical cancer, Stomach cance …
Latest industry research report on Cancer vaccines are the type of immunotherapy (also named as biologic therapy), designed to boost body's natural defense against cancer. The body's natural immune system recognizes vaccine proteins as the foreign particles and sets up an immunity against them. According to World Health Organization (WHO), cancer is a leading cause of worldwide mortality registering ~14 million new cases and ~8.2 million cancer-related diseases in 2012. Personalized
Taking thyroid cancer seriously
With the increasing incidence rate of thyroid cancer in Metro Cebu, the Eduardo J. Aboitiz Cancer Center (EJACC) of the Ramon Aboitiz Foundation Inc. (RAFI) urged the public to undergo early screening and prevention measures to fight the disease. “Thyroid cancer is high on prognosis. It is preventable through various screening methods, such as physical examination and ultrasound of the neck, as well as some prevention measures, including regular exercise and